Navigation Links
Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Date:2/19/2013

assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance.  Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans" and similar expressions.  Although Sanofi's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements.  These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the absence of guarantee that the product candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group's ability to benefit from external growth opportunities, trends in exchange rates and prevailing interest rates, the impact of cost containment policies and subsequent changes thereto, the average number of shares outstanding as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary
'/>"/>
SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Bayer HealthCare (Bayer) has entered ... (NASDAQ: ISIS ) on ISIS-FXI Rx, an ... of thrombosis. Under the agreement Bayer will further develop ... unmet medical need. As part of the clinical development ... ISIS-FXI Rx in an appropriate patient community. ...
(Date:5/4/2015)... FRAMINGHAM, Mass. , May 4, 2015   HeartWare ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... and CEO, Doug Godshall , is scheduled to present ... Conference in Las Vegas on Thursday, ... The live webcast of the Company,s presentation at ...
(Date:5/4/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) has entered ... to develop and commercialize ISIS-FXI Rx for the ... Isis is eligible to receive up to $155 million ... payment and a $55 million payment upon advancement of ... with compromised kidney function. Isis is also eligible to ...
Breaking Medicine Technology:Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
... honor of National Women,s Health Week, Someone With ... home health and medical supply online storefront, www.someonewith.com , ... catalog solutions for more than 2.5 million breast cancer survivors ... women who will be diagnosed with breast cancer this year. ...
... (NYSE Amex: ANX ) today reported financial results ... "We are pleased to have completed the acquisition of SynthRx ... to reach agreement on the protocol for a pivotal phase ... crisis," said Brian M. Culley, Chief Executive Officer of ADVENTRX. ...
Cached Medicine Technology:Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 2Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 3Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 4ADVENTRX Reports First Quarter 2011 Financial Results 2ADVENTRX Reports First Quarter 2011 Financial Results 3ADVENTRX Reports First Quarter 2011 Financial Results 4ADVENTRX Reports First Quarter 2011 Financial Results 5
(Date:5/5/2015)... (PRWEB) May 05, 2015 ... H2 2014” provides comparative analysis on the ... strengthens R&D pipelines by identifying new targets ... products. Complete report is available at ... this Liver Fibrosis – Pipeline Review, H2 ...
(Date:5/5/2015)... Woodbridge, NJ (PRWEB) May 05, 2015 Texting ... it is no surprise that some physicians text as a ... always, we urge providers who are doing so to assure ... Texting does not come without risk! When providers transmit ... their mobile devices, they run the risk of violating the ...
(Date:5/5/2015)... No one cares about health problems until ... and Prevention cite multiple sources causing poor indoor air ... air quality (pollution) can bother your eyes, nose, and throat. ... and cancer.” , Toxic chemicals often get into the human ... water, or in some cases, absorb them through our skin. ...
(Date:5/4/2015)... Garden City, NY (PRWEB) May 05, 2015 ... honors Patti Hommes as a 2015-2016 ... She is recognized with this prestigious distinction for leadership ... exclusively for professional women, boasting more than 700,000 members ... to recognize Patti with this important honor,” says NAPW ...
(Date:5/4/2015)... Every Friday afternoon at A Forever Recovery, a ... patients and staff gather in the common room to ... and to gain encouragement and inspiration in their continuing ... one, those patients who have completed their recovery programs ... to share a bit about their journey with the ...
Breaking Medicine News(10 mins):Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 2Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 3Health News:HIPAA Compliant Texting Service from MedXcom now available for Policyholders 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 3Health News:NAPW Inducts Patti Hommes, Director of Advancement Services, Springside Chestnut Hill Academy, a 2015-2016 Professional Woman of the Year Circle 2Health News:A Forever Recovery Celebrates New Victories in Overcoming Addiction With Weekly Graduation 2
... News) -- The worldwide diabetes epidemic continues to worsen, ... disease, 4.6 million deaths due to it each year, ... International Diabetes Federation announced Tuesday. The federation ... Association for the Study of Diabetes in Lisbon, Portugal, ...
... case-control and cohort studies on the association of alcohol consumption ... from Asia, 2 from Australia, 13 from Western Europe, and ... alcohol, at least at higher levels of consumption, is associated ... Overall, there was no increase in the risk for consumers ...
... to be presented at the upcoming HFES 55th Annual ... describe WISE, a Web-based tool for breast cancer survivors ... Those who have beaten breast cancer comprise the ... Many return to the workplace after treatment, but symptoms ...
... HealthDay Reporter , TUESDAY, Sept. 13 (HealthDay News) -- ... developing high blood pressure than whites are, but new research ... state to full-blown high blood pressure. The ... Hypertension , suggest that intervening earlier with medication, as ...
... against cervical cancer. This is the conclusion of the broadest ... group in Viruses and Cancer of IDIBELL, published at ... who uses IUD halved the risk of developing cervical cancer ... are contrary to popular belief that IUD could be a ...
... Alan Mozes HealthDay Reporter , MONDAY, Sept. 12 ... by the U.S. Food and Drug Administration are foolproof and ... But when informed of safety concerns about a drug, ... important gaps in what people know about approved drugs, and ...
Cached Medicine News:Health News:366 Million People Now Have Diabetes: Report 2Health News:Relation of alcohol consumption to colorectal cancer 2Health News:Web tool aims to improve the workplace for breast cancer survivors 2Health News:Blacks Develop High Blood Pressure a Year Ahead of Whites 2Health News:IUD reduces the risk of cervical cancer 2Health News:Public Often Unaware of a Drug's Safety Record -- Or Lack of One 2Health News:Public Often Unaware of a Drug's Safety Record -- Or Lack of One 3Health News:Public Often Unaware of a Drug's Safety Record -- Or Lack of One 4
The design of this table top is based on advanced functionality for specific urological requirements. This composite product sets a new standard for urological imaging....
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential....
... KCIs First Step Select® Heavy Duty is ... add low air loss therapy specifically to the ... weighing between 250 and 650 lbs., Large patients ... large patient using a static mattress that would ...
... a healthcare bed system which helps provide ... home care setting, ,INDICATIONS: ,Patients weighing ... 2) ,Healthcare frame accommodating one or ... ,CONTRAINDICATIONS: ,Total weight in excess of ...
Medicine Products: